Published • loading... • Updated
Federal Judge Delays a Mifepristone Lawsuit Until After Midterms
Judge Reed O'Connor delayed the case until Dec. 1 as the Food and Drug Administration continues a six-month safety review of mifepristone.
- On Sunday, Chief District Judge Reed O'Connor paused a lawsuit from Florida and Texas seeking to revoke nationwide mifepristone approval, delaying the case until at least December 1 to allow the Food and Drug Administration to continue its safety review.
- Citing the 150-year-old Comstock Act, Florida and Texas attorneys general filed the lawsuit seeking to permanently revoke the agency's 2000 approval of the medication and subsequent decisions easing patient access.
- Mifepristone is commonly used to terminate pregnancies before 10 weeks; the FDA began a six-month safety study in June, which prompted the stay request and delayed litigation.
- In the same ruling, O'Connor denied a motion to dismiss from distributor Danco Laboratories and GenBioPro, one of the drug's main manufacturers, allowing the case to proceed.
- Additional legal challenges persist, including a case before the 5th Circuit Court of Appeals set for September 9 in which anti-abortion groups seek to remove remote-dispensing rules.
Insights by Ground AI
15 Articles
15 Articles
Federal judge delays a mifepristone lawsuit until after midterms
A federal judge on Sunday paused a lawsuit seeking to revoke the Food and Drug Administration’s approval of the abortion pill mifepristone until after the midterm elections. Judge Reed O’Connor of the U.S. District Court for the Northern District of Texas granted a request by the Department of Justice to delay the lawsuit filed by…
·Washington, United States
Read Full Article
Federal judge pauses case on mifepristone access until after midterm elections • Oklahoma Voice
A federal judge in Texas on Sunday paused a lawsuit seeking to revoke nationwide approval of the abortion drug mifepristone, saying the case won’t be heard until at least Dec. 1 and granting the U.S. Food and Drug Administration’s request for a stay to continue its safety review of the drug. The Republican attorneys general […]
Coverage Details
Total News Sources15
Leaning Left13Leaning Right0Center2Last UpdatedBias Distribution87% Left
Bias Distribution
- 87% of the sources lean Left
87% Left
L 87%
13%
Factuality
To view factuality data please Upgrade to Premium
